Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2025)
Historic Receivables for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $5.2 million.
- Zhengye Biotechnology Holding's Receivables changed N/A to $5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $10.6 million for FY2024, which is 2056.92% down from last year.
- Latest data reveals that Zhengye Biotechnology Holding reported Receivables of $5.2 million as of Q2 2025.
- Zhengye Biotechnology Holding's 5-year Receivables high stood at $13.1 million for Q4 2023, and its period low was $5.2 million during Q2 2025.
- Its 3-year average for Receivables is $8.9 million, with a median of $8.4 million in 2024.
- Examining YoY changes over the last 5 years, Zhengye Biotechnology Holding's Receivables showed a top increase of 3575.58% in 2024 and a maximum decrease of 3575.58% in 2024.
- Quarter analysis of 3 years shows Zhengye Biotechnology Holding's Receivables stood at $13.1 million in 2023, then tumbled by 35.76% to $8.4 million in 2024, then crashed by 37.95% to $5.2 million in 2025.
- Its Receivables stands at $5.2 million for Q2 2025, versus $8.4 million for Q4 2024 and $13.1 million for Q4 2023.